Delivery Order 75N95023D00007-75N95023F00001

Award Date 3/29/23
Potential Completion Date 3/28/28
Potential Value $38K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to New York Genome Center, Inc. (Nygc), a nonprofit academic research institution, by the National Institute of Mental Health (NIMH), a civilian agency. The $73,817,033 contract is a delivery order under the BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core master IDIQ, which Nygc holds. Under this contract, Nygc will provide specialized genomic sequencing and analysis services to support major federal biomedical research initiatives. The contract...
This is a delivery order awarded to The Broad Institute, Inc. under the Brain Initiative Cell Atlas Network (BICAN) Sequencing Core master contract. The $5,000 order is for Task Area 1: Manual of Operations services related to the BICAN program, which is funded by the National Institute of Mental Health (NIMH). The Broad Institute, a non-profit research organization, is the prime contractor and will perform the work at its facility in Cambridge, MA. The BICAN program is a large-scale NIH...
This is a Firm Fixed Price delivery order awarded by the National Cancer Institute (NCI) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution, for a Single Cell Sequencing Task Order under the NCI Genomic Characterization Centers master IDIQ contract. The period of performance is from September 16, 2019 to September 15, 2022, with a ceiling value of $190,664.68. The order is in support of NCI's Center for Cancer Genomics program and does not have a set-aside...
This is a delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to the New York Genome Center, Inc. (Nygc), a nonprofit academic research institution. The $742,360.00 firm fixed price contract is for Nygc to provide RNA sequencing services as part of the NHLBI Trans-Omics for Precision Medicine (TOPMed) program, which involves centralized multi-omics data analysis and management to support large health...
This is a $274,036 fixed-price task order awarded to the New York Genome Center, Inc. (Nygc) by the National Cancer Institute (NCI) under the NCI Genomic Characterization Centers master IDIQ contract. The purpose is to provide DNA methylation arrays to support new studies by the Cancer Genomics Program over a 3-year period of performance from September 2020 to September 2023. This task order is fully funded and non-severable. Nygc is a nonprofit academic research institution that provides...
This is a firm fixed price delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to the New York Genome Center, Inc. (NYGC), a nonprofit research institution. The $7,001,570.38 contract is for RNA sequencing services as part of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) program, which involves a centralized omics data analysis and management resource. NYGC has held a $500 million IDIQ contract with NHLBI to support TOPMed. This specific 2024 task...
This is a $13,468,050.00 definitive, firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for special studies and analysis services, with no set-aside designation. NYGC has a $500 million indefinite delivery, indefinite quantity (IDIQ) contract with NHLBI for the Trans-Omics for Precision Medicine (TOPMed) program to provide...
This is a $61,697.50 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 2 to the nonprofit New York Genome Center, Inc. (doing business as Nygc) for sequencing services. The award does not have a set-aside designation. Nygc is a leading academic research institution that specializes in genomic sequencing, analysis, and computational services for federal agencies. It has delivered these services to various NIH institutes as well...
This is a delivery order award to the New York Genome Center, Inc. (doing business as Nygc), a nonprofit academic research institution, under the Centralized Omic REsource for TOPMed (CORE) Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Heart, Lung, and Blood Institute (NHLBI). The order, valued at $5,906,039.00, is for the fifth year of the Centralized Omics Resource (CORE) project, which provides centralized omics data analysis and management services to support...
This is a firm fixed price delivery order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. The $23,921.70 order is for the procurement of various 10X Genomics products including single cell kits for RNA sequencing, BCR and TCR amplification, and dual index kits. These specialized reagents and consumables support NINDS research efforts related to neurological diseases and disorders. The award...

This is a delivery order issued under the $149 million Brain Initiative Cell Atlas Network (BICAN) Sequencing Core indefinite delivery contract awarded by the National Institute on Drug Abuse (NIDA). The $38,000 firm-fixed-price task order was awarded to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution, to support the BICAN program's sequencing and genomic characterization services. The task order is for NYGC to provide a manual of operations for the BICAN sequencing core. This delivery order does not have a set-aside designation, reflecting the specialized nature of the genomic services being provided. NYGC has a history of delivering next-generation sequencing, whole genome sequencing, RNA sequencing, and other genomic analysis services to support major federal biomedical research initiatives at agencies like the NIH and VA.

Generated 3/29/25, 9:46 AM